drugset / Trial / NCT04597203

Efficacy and Safety of Using Combination of 755-nm Picosecond Alexandrite Laser and 2% Hydroquinone Compared With 2% Hydroquinone Alone for the Treatment of Melasma: a Randomized Split-face Controlled Trial

NCT04597203

Unknown 20 enrolled Mahidol University
RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims to assess the efficacy and safety of using combination of 755-nm picosecond alexandrite laser and 2% hydroquinone compared with 2% hydroquinone alone for the treatment of melasma: A randomized split-face controlled trial

Timeline

Start
2020-10
Primary completion
2021-01
Completion
2021-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydroquinone Small molecule 2 % Topical